These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18221198)

  • 1. Therapeutic perspectives in Alzheimer's disease.
    Tschäpe JA; Hartmann T
    Recent Pat CNS Drug Discov; 2006 Jan; 1(1):119-27. PubMed ID: 18221198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-modifying therapies in Alzheimer's disease: how far have we come?
    Hüll M; Berger M; Heneka M
    Drugs; 2006; 66(16):2075-93. PubMed ID: 17112302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD).
    Lukiw WJ
    Expert Opin Emerg Drugs; 2008 Jun; 13(2):255-71. PubMed ID: 18537520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging beta-amyloid therapies for the treatment of Alzheimer's disease.
    Conway KA; Baxter EW; Felsenstein KM; Reitz AB
    Curr Pharm Des; 2003; 9(6):427-47. PubMed ID: 12570807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid inhibitors and Alzheimer's disease.
    Xia W
    Curr Opin Investig Drugs; 2003 Jan; 4(1):55-9. PubMed ID: 12625030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can statins put the brakes on Alzheimer's disease?
    Whitfield JF
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1479-85. PubMed ID: 17107274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-cholinergic strategies for treating and preventing Alzheimer's disease.
    Doraiswamy PM
    CNS Drugs; 2002; 16(12):811-24. PubMed ID: 12421115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the development of new drugs in Alzheimer's disease.
    Piau A; Nourhashémi F; Hein C; Caillaud C; Vellas B
    J Nutr Health Aging; 2011 Jan; 15(1):45-57. PubMed ID: 21267520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Alzheimer's disease].
    Ishiura S; Hattori C
    Tanpakushitsu Kakusan Koso; 2004 Nov; 49(14):2179-85. PubMed ID: 15559301
    [No Abstract]   [Full Text] [Related]  

  • 12. Beta-secretase inhibitors in phase I and phase II clinical trials for Alzheimer's disease.
    Moussa CE
    Expert Opin Investig Drugs; 2017 Oct; 26(10):1131-1136. PubMed ID: 28817311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The past, present, and future of disease-modifying therapies for Alzheimer's disease.
    Suzuki K; Iwata A; Iwatsubo T
    Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(10):757-771. PubMed ID: 29225305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease modifying drugs targeting β-amyloid.
    Ozudogru SN; Lippa CF
    Am J Alzheimers Dis Other Demen; 2012 Aug; 27(5):296-300. PubMed ID: 22815077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer's disease: progress in the development of anti-amyloid disease-modifying therapies.
    Christensen DD
    CNS Spectr; 2007 Feb; 12(2):113-6, 119-23. PubMed ID: 17277711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic strategies for Alzheimer's disease in clinical trials.
    Godyń J; Jończyk J; Panek D; Malawska B
    Pharmacol Rep; 2016 Feb; 68(1):127-38. PubMed ID: 26721364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's therapeutics: continued clinical failures question the validity of the amyloid hypothesis-but what lies beyond?
    Mullane K; Williams M
    Biochem Pharmacol; 2013 Feb; 85(3):289-305. PubMed ID: 23178653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HMG-CoA reductase inhibitors on beta-amyloid peptide levels: implications for Alzheimer's disease.
    Höglund K; Blennow K
    CNS Drugs; 2007; 21(6):449-62. PubMed ID: 17521225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol and Alzheimer's disease: statins, cholesterol depletion in APP processing and Abeta generation.
    Hartman T
    Subcell Biochem; 2005; 38():365-80. PubMed ID: 15709489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and cellular basis for anti-amyloid therapy in Alzheimer disease.
    Gandy S; Martins RN; Buxbaum J
    Alzheimer Dis Assoc Disord; 2003; 17(4):259-66. PubMed ID: 14657791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.